Richard Nolan Townsend, Chief Executive Officer at Lexeo Therapeutics, sold LXEO on Aug 18, 2026
Data as of Oct 27
▼ SELL$16.6K3,345 shares at $4.95Richard Nolan Townsend Chief Executive OfficerLXEO Lexeo Therapeutics, Inc.
- Traded
- Aug 18, 2026
- Disclosed
- Aug 19, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
LXEO since disclosure
−46.6%
after the sale
Similar stocks (XLV) since disclosure
+2.0%
XLV — its sector index fund
Change in closing price from Aug 19, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.